Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
35M
Number of holders
130
Total 13F shares, excl. options
27.3M
Shares change
-583K
Total reported value, excl. options
$1.34B
Value change
-$26.6M
Put/Call ratio
0.99
Number of buys
81
Number of sells
-37
Price
$49.14

Significant Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q3 2024

147 filings reported holding IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share as of Q3 2024.
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27.3M shares of 35M outstanding shares and own 78.06% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (2.51M shares), BlackRock, Inc. (1.85M shares), WELLINGTON MANAGEMENT GROUP LLP (1.84M shares), Bain Capital Life Sciences Investors, LLC (1.8M shares), ORBIMED ADVISORS LLC (1.79M shares), Frazier Life Sciences Management, L.P. (1.75M shares), Paradigm Biocapital Advisors LP (1.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.13M shares), VANGUARD GROUP INC (1.05M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.02M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.